{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:33:41Z","timestamp":1780760021641,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T00:00:00Z","timestamp":1618099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10930-021-09983-8","type":"journal-article","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T02:02:15Z","timestamp":1618106535000},"page":"310-327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Milk Peptides as Novel Multi\u2010Targeted Therapeutic Candidates for SARS-CoV2"],"prefix":"10.1007","volume":"40","author":[{"given":"H.","family":"Pradeep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umme","family":"Najma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Aparna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,11]]},"reference":[{"key":"9983_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nfs.2020.06.001","volume":"20","author":"HK Biesalski","year":"2020","unstructured":"Biesalski HK (2020) Vitamin D deficiency and co-morbidities in COVID-19 patients\u2014a fatal relationship? NFS J 20:10\u201321. https:\/\/doi.org\/10.1016\/j.nfs.2020.06.001","journal-title":"NFS J"},{"key":"9983_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","volume":"361","author":"JSM Peiris","year":"2003","unstructured":"Peiris JSM, Lai ST, Poon LLM et al (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319\u20131325. https:\/\/doi.org\/10.1016\/S0140-6736(03)13077-2","journal-title":"Lancet"},{"key":"9983_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/aps.2014.125","volume":"36","author":"J Liu","year":"2015","unstructured":"Liu J, Wang Z (2015) Diverse array-designed modes of combination therapies in Fangjiomics. Acta Pharmacol Sin 36:680\u2013688","journal-title":"Acta Pharmacol Sin"},{"key":"9983_CR4","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1007\/s00216-017-0793-9","volume":"410","author":"AB Nongonierma","year":"2018","unstructured":"Nongonierma AB, FitzGerald RJ (2018) Enhancing bioactive peptide release and identification using targeted enzymatic hydrolysis of milk proteins. Anal Bioanal Chem 410:3407\u20133423. https:\/\/doi.org\/10.1007\/s00216-017-0793-9","journal-title":"Anal Bioanal Chem"},{"key":"9983_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173781","author":"B \u00c7ak\u0131r","year":"2021","unstructured":"\u00c7ak\u0131r B, Okuyan B, \u015eener G, Tunali-Akbay T (2021) Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): in silico analysis. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173781","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"9983_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1021\/acsptsci.0c00059","volume":"3","author":"S Elnagdy","year":"2020","unstructured":"Elnagdy S, Alkhazindar M (2020) The potential of antimicrobial peptides as an antiviral therapy against COVID-19. ACS Pharmacol Transl Sci 3(4):780\u2013782","journal-title":"ACS Pharmacol Transl Sci"},{"key":"9983_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.foodchem.2017.02.032","volume":"228","author":"NR Ashok","year":"2017","unstructured":"Ashok NR, Aparna HS (2017) Empirical and bioinformatic characterization of buffalo (Bubalus bubalis) colostrum whey peptides and their angiotensin I-converting enzyme inhibition. Food Chem 228:582\u2013594. https:\/\/doi.org\/10.1016\/j.foodchem.2017.02.032","journal-title":"Food Chem"},{"key":"9983_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejmech.2012.03.057","volume":"53","author":"AC Rohit","year":"2012","unstructured":"Rohit AC, Sathisha K, Aparna HS (2012) A variant peptide of buffalo colostrum \u03b2-lactoglobulin inhibits angiotensin I-converting enzyme activity. Eur J Med Chem 53:211\u2013219. https:\/\/doi.org\/10.1016\/j.ejmech.2012.03.057","journal-title":"Eur J Med Chem"},{"key":"9983_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijbiomac.2016.03.049","volume":"88","author":"MB Mamatha","year":"2016","unstructured":"Mamatha MB, Nishimura SI (2016) Inhibitory potential of Buffalo (Bubalus bubalis) colostrum immunoglobulin G on Klebsiella pneumoniae. Int J Biol Macromol 88:138\u2013145. https:\/\/doi.org\/10.1016\/j.ijbiomac.2016.03.049","journal-title":"Int J Biol Macromol"},{"key":"9983_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.foodres.2017.03.037","volume":"97","author":"N Brijesha","year":"2017","unstructured":"Brijesha N, Aparna HS (2017) Comprehensive characterization of bioactive peptides from Buffalo (Bubalus bubalis) colostrum and milk fat globule membrane proteins. Food Res Int 97:95\u2013103. https:\/\/doi.org\/10.1016\/j.foodres.2017.03.037","journal-title":"Food Res Int"},{"key":"9983_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejmech.2019.07.009","volume":"180","author":"A Ashok","year":"2019","unstructured":"Ashok A, Brijesha N, Aparna HS (2019) Discovery, synthesis, and in vitro evaluation of a novel bioactive peptide for ACE and DPP-IV inhibitory activity. Eur J Med Chem 180:99\u2013110. https:\/\/doi.org\/10.1016\/j.ejmech.2019.07.009","journal-title":"Eur J Med Chem"},{"key":"9983_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377\u2013389. https:\/\/doi.org\/10.1021\/ci800324m","journal-title":"J Chem Inf Model"},{"key":"9983_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2016","unstructured":"Harder E, Damm W, Maple J et al (2016) OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 12:281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864","journal-title":"J Chem Theory Comput"},{"key":"9983_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/acs.jcim.6b00443","volume":"57","author":"H Alogheli","year":"2017","unstructured":"Alogheli H, Olanders G, Schaal W et al (2017) Docking of macrocycles: comparing rigid and flexible docking in Glide. J Chem Inf Model 57:190\u2013202. https:\/\/doi.org\/10.1021\/acs.jcim.6b00443","journal-title":"J Chem Inf Model"},{"key":"9983_CR15","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B et al (2005) GROMACS: fast, flexible, and free. J Comput Chem 26:1701\u20131718","journal-title":"J Comput Chem"},{"key":"9983_CR16","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1021\/acs.jctc.5b00356","volume":"11","author":"MJ Robertson","year":"2015","unstructured":"Robertson MJ, Tirado-Rives J, Jorgensen WL (2015) Improved peptide and protein torsional energetics with the OPLS-AA force field. J Chem Theory Comput 11:3499\u20133509. https:\/\/doi.org\/10.1021\/acs.jctc.5b00356","journal-title":"J Chem Theory Comput"},{"key":"9983_CR17","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys. https:\/\/doi.org\/10.1063\/1.2408420","journal-title":"J Chem Phys"},{"issue":"2","key":"9983_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00018-020-03611-x","volume":"78","author":"J Wu","year":"2020","unstructured":"Wu J, Deng W, Li S, Yang X (2020) Advances in research on ACE2 as a receptor for 2019-nCoV. Cell Mol Life Sci 78(2):531\u2013544","journal-title":"Cell Mol Life Sci"},{"key":"9983_CR19","doi-asserted-by":"publisher","first-page":"307315","DOI":"10.1155\/2012\/307315","volume":"2012","author":"NE Clarke","year":"2012","unstructured":"Clarke NE, Turner AJ (2012) Angiotensin-converting enzyme 2: the first decade. Int J Hypertens 2012:307315. https:\/\/doi.org\/10.1155\/2012\/307315","journal-title":"Int J Hypertens"},{"key":"9983_CR20","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu X-F et al (2020) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41:1141\u20131149","journal-title":"Acta Pharmacol Sin"},{"key":"9983_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00382-20","author":"N Shekhar","year":"2020","unstructured":"Shekhar N, Sarma P, Prajapat M et al (2020) In silico structure-based repositioning of approved drugs for Spike glycoprotein S2 domain fusion peptide of SARS-CoV-2: rationale from molecular dynamics and binding free energy calculations. mSystems. https:\/\/doi.org\/10.1128\/msystems.00382-20","journal-title":"mSystems"},{"key":"9983_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576745","author":"D Zipeto","year":"2020","unstructured":"Zipeto D, da Palmeira JF, Arga\u00f1araz GA, Arga\u00f1araz ER (2020) ACE2\/ADAM17\/TMPRSS2 interplay may be the main risk factor for COVID-19. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.576745","journal-title":"Front Immunol"},{"key":"9983_CR23","doi-asserted-by":"publisher","first-page":"107587","DOI":"10.1016\/j.pharmthera.2020.107587","volume":"213","author":"T Liu","year":"2020","unstructured":"Liu T, Luo S, Libby P, Shi GP (2020) Cathepsin L-selective inhibitors: a potentially promising treatment for COVID-19 patients. Pharmacol Ther 213:107587","journal-title":"Pharmacol Ther"},{"key":"9983_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1021\/acschemneuro.0c00251","volume":"11","author":"CMS Singal","year":"2020","unstructured":"Singal CMS, Jaiswal P, Seth P (2020) SARS-CoV-2, more than a respiratory virus: its potential role in neuropathogenesis. ACS Chem Neurosci 11:1887\u20131899","journal-title":"ACS Chem Neurosci"},{"key":"9983_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpclett.0c01698","author":"N Vankadari","year":"2020","unstructured":"Vankadari N (2020) Structure of furin protease binding to SARS-CoV-2 spike glycoprotein and implications for potential targets and virulence. J Phys Chem Lett. https:\/\/doi.org\/10.1021\/acs.jpclett.0c01698","journal-title":"J Phys Chem Lett"},{"key":"9983_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00606","author":"C Gil","year":"2020","unstructured":"Gil C, Ginex T, Maestro I et al (2020) COVID-19: drug targets and potential treatments. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00606","journal-title":"J Med Chem"},{"key":"9983_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13877","author":"AM Sayed","year":"2020","unstructured":"Sayed AM, Khalaf AM, Abdelrahim MEA, Elgendy MO (2020) Repurposing of some anti-infective drugs for COVID-19 treatment: a surveillance study supported by an in silico investigation. Int J Clin Pract. https:\/\/doi.org\/10.1111\/ijcp.13877","journal-title":"Int J Clin Pract"},{"key":"9983_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BJ20131399","volume":"459","author":"A Chaikuad","year":"2014","unstructured":"Chaikuad A, Keates T, Vincke C et al (2014) Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies. Biochem J 459:59\u201369. https:\/\/doi.org\/10.1042\/BJ20131399","journal-title":"Biochem J"},{"key":"9983_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature25146","volume":"552","author":"K He","year":"2017","unstructured":"He K, Marsland R, Upadhyayula S et al (2017) Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic. Nature 552:410\u2013414. https:\/\/doi.org\/10.1038\/nature25146","journal-title":"Nature"},{"key":"9983_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1128\/mcb.19.1.623","volume":"19","author":"A Shisheva","year":"1999","unstructured":"Shisheva A, Sbrissa D, Ikonomov O (1999) Cloning, characterization, and expression of a novel Zn2+-binding FYVE finger-containing phosphoinositide kinase in insulin-sensitive cells. Mol Cell Biol 19:623\u2013634. https:\/\/doi.org\/10.1128\/mcb.19.1.623","journal-title":"Mol Cell Biol"},{"key":"9983_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.molcel.2020.10.003","volume":"80","author":"JA Lees","year":"2020","unstructured":"Lees JA, Li PQ, Kumar N et al (2020) Insights into lysosomal PI(3, 5)P2 homeostasis from a structural-biochemical analysis of the PIKfyve lipid kinase complex. Mol Cell 80:736-743.e4. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.003","journal-title":"Mol Cell"},{"key":"9983_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.653","author":"PM Heister","year":"2020","unstructured":"Heister PM, Poston RN (2020) Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19. Pharmacol Res Perspect. https:\/\/doi.org\/10.1002\/prp2.653","journal-title":"Pharmacol Res Perspect"},{"key":"9983_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.45222","author":"J She","year":"2019","unstructured":"She J, Zeng W, Guo J et al (2019) Structural mechanisms of phospholipid activation of the human TPC2 channel. eLife. https:\/\/doi.org\/10.7554\/eLife.45222","journal-title":"eLife"},{"key":"9983_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2013.11.040","volume":"450\u2013451","author":"AM Mielech","year":"2014","unstructured":"Mielech AM, Kilianski A, Baez-Santos YM et al (2014) MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology 450\u2013451:64\u201370. https:\/\/doi.org\/10.1016\/j.virol.2013.11.040","journal-title":"Virology"},{"key":"9983_CR35","doi-asserted-by":"publisher","first-page":"14958","DOI":"10.1021\/bi0490237","volume":"43","author":"CY Chou","year":"2004","unstructured":"Chou CY, Chang HC, Hsu WC et al (2004) Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry 43:14958\u201314970. https:\/\/doi.org\/10.1021\/bi0490237","journal-title":"Biochemistry"},{"key":"9983_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.1077742020.107774","author":"Q Peng","year":"2020","unstructured":"Peng Q, Peng R, Yuan B et al (2020) Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2020.1077742020.107774","journal-title":"Cell Rep"},{"key":"9983_CR37","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001203","author":"R Pokhrel","year":"2020","unstructured":"Pokhrel R, Chapagain P, Siltberg-Liberles J (2020) Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2. J Med Microbiol. https:\/\/doi.org\/10.1099\/jmm.0.001203","journal-title":"J Med Microbiol"},{"key":"9983_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02439-0","author":"SO Aftab","year":"2020","unstructured":"Aftab SO, Ghouri MZ, Masood MU et al (2020) Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-020-02439-0","journal-title":"J Transl Med"},{"key":"9983_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virusres.2014.12.001","volume":"202","author":"KC Lehmann","year":"2015","unstructured":"Lehmann KC, Snijder EJ, Posthuma CC, Gorbalenya AE (2015) What we know but do not understand about nidovirus helicases. Virus Res 202:12\u201332. https:\/\/doi.org\/10.1016\/j.virusres.2014.12.001","journal-title":"Virus Res"},{"key":"9983_CR40","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/nejmoa1211721","volume":"367","author":"AM Zaki","year":"2012","unstructured":"Zaki AM, van Boheemen S, Bestebroer TM et al (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814\u20131820. https:\/\/doi.org\/10.1056\/nejmoa1211721","journal-title":"N Engl J Med"},{"key":"9983_CR41","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1073\/pnas.1407087111","volume":"111","author":"JK Mille","year":"2014","unstructured":"Mille JK, Whittaker GR (2014) Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci USA 111:15214\u201315219. https:\/\/doi.org\/10.1073\/pnas.1407087111","journal-title":"Proc Natl Acad Sci USA"},{"key":"9983_CR42","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.1128\/jvi.03372-12","volume":"87","author":"S Bertram","year":"2013","unstructured":"Bertram S, Dijkman R, Habjan M et al (2013) TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol 87:6150\u20136160. https:\/\/doi.org\/10.1128\/jvi.03372-12","journal-title":"J Virol"},{"key":"9983_CR43","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1128\/jvi.05300-11","volume":"85","author":"S Bertram","year":"2011","unstructured":"Bertram S, Glowacka I, Muller MA et al (2011) Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 85:13363\u201313372. https:\/\/doi.org\/10.1128\/jvi.05300-11","journal-title":"J Virol"},{"key":"9983_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.meegid.2007.07.004","volume":"8","author":"M Surjit","year":"2008","unstructured":"Surjit M, Lal SK (2008) The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol 8:397\u2013405","journal-title":"Infect Genet Evol"},{"key":"9983_CR45","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","volume":"24","author":"W Ni","year":"2020","unstructured":"Ni W, Yang X, Yang D et al (2020) Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care 24:422","journal-title":"Crit Care"},{"key":"9983_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2478\/jtim-2020-0003","volume":"8","author":"M Liu","year":"2020","unstructured":"Liu M, Wang T, Zhou Y et al (2020) Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management. J Transl Intern Med 8:9\u201319. https:\/\/doi.org\/10.2478\/jtim-2020-0003","journal-title":"J Transl Intern Med"},{"key":"9983_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.002152020.00215","author":"S Seth","year":"2020","unstructured":"Seth S, Batra J, Srinivasan S (2020) COVID-19: targeting proteases in viral invasion and host immune response. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2020.002152020.00215","journal-title":"Front Mol Biosci"},{"key":"9983_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.1016422020.101642","author":"C Wu","year":"2020","unstructured":"Wu C, Zheng M, Yang Y et al (2020) Furin: a potential therapeutic target for COVID-19. iScience. https:\/\/doi.org\/10.1016\/j.isci.2020.1016422020.101642","journal-title":"iScience"},{"key":"9983_CR49","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s10989-018-9795-5","volume":"25","author":"NR Ashok","year":"2019","unstructured":"Ashok NR, Vivek KH, Aparna HS (2019) Antioxidative role of Buffalo (Bubalus bubalis) colostrum whey derived peptides during oxidative damage. Int J Pept Res Ther 25:1501\u20131508. https:\/\/doi.org\/10.1007\/s10989-018-9795-5","journal-title":"Int J Pept Res Ther"},{"key":"9983_CR50","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1128\/jvi.02705-14","volume":"89","author":"G Neveu","year":"2015","unstructured":"Neveu G, Ziv-Av A, Barouch-Bentov R et al (2015) AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets. J Virol 89:4387\u20134404. https:\/\/doi.org\/10.1128\/jvi.02705-14","journal-title":"J Virol"},{"key":"9983_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.009702020.00970","author":"A Filippini","year":"2020","unstructured":"Filippini A, D\u2019Amore A, Palombi F, Carpaneto A (2020) Could the inhibition of endo-lysosomal two-pore channels (TPCs) by the natural flavonoid naringenin represent an option to fight SARS-CoV-2 infection? Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.009702020.00970","journal-title":"Front Microbiol"},{"key":"9983_CR52","doi-asserted-by":"publisher","first-page":"20803","DOI":"10.1073\/pnas.2007837117","volume":"117","author":"YL Kang","year":"2020","unstructured":"Kang YL, Chou YY, Rothlauf PW et al (2020) Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. Proc Natl Acad Sci USA 117:20803\u201320813. https:\/\/doi.org\/10.1073\/pnas.2007837117","journal-title":"Proc Natl Acad Sci USA"},{"key":"9983_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/SCITRANSLMED.ABC5332","author":"AD Rathnayake","year":"2020","unstructured":"Rathnayake AD, Zheng J, Kim Y et al (2020) 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV\u2013infected mice. Sci Transl Med. https:\/\/doi.org\/10.1126\/SCITRANSLMED.ABC5332","journal-title":"Sci Transl Med"},{"key":"9983_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117477","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.117477","journal-title":"Life Sci"},{"key":"9983_CR55","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41551-020-0556-3","volume":"4","author":"XD Kong","year":"2020","unstructured":"Kong XD, Moriya J, Carle V et al (2020) De novo development of proteolytically resistant therapeutic peptides for oral administration. Nat Biomed Eng 4:560\u2013571. https:\/\/doi.org\/10.1038\/s41551-020-0556-3","journal-title":"Nat Biomed Eng"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-021-09983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-021-09983-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-021-09983-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:38:15Z","timestamp":1667522295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-021-09983-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9983"],"URL":"https:\/\/doi.org\/10.1007\/s10930-021-09983-8","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"value":"1572-3887","type":"print"},{"value":"1875-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,11]]},"assertion":[{"value":"29 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}